ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 1187

$477K Total Retail Price of All Prescriptions

Rank: 197 out of 1187

522 Patients Receiving at Least One Drug in Part D
100%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 522 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 433 433 1 3
FUROSEMIDE 381 381 2 8
POTASSIUM CHLORIDE 304 304 3 32
AMLODIPINE BESYLATE 301 301 4 2
SIMVASTATIN 296 296 5 1
OMEPRAZOLE 210 210 6 5
ATORVASTATIN CALCIUM 206 206 7 6
LISINOPRIL 201 201 8 4
WARFARIN SODIUM 194 194 9 13
DONEPEZIL HCL 188 182 10 26
METOPROLOL SUCCINATE 186 186 11 11
MIRTAZAPINE 174 174 12 54
METOPROLOL TARTRATE 159 159 13 10
POLYETHYLENE GLYCOL 3350 109 109 14 86
HYDROCHLOROTHIAZIDE 109 109 14 9
NAMENDA 107 107 16 44
SERTRALINE HCL 105 105 17 22
CARBIDOPA-LEVODOPA 91 91 18 99
CYMBALTA 91 91 18 60
LOSARTAN POTASSIUM 85 85 20 21
DIGOXIN 82 82 21 65
GABAPENTIN 79 79 22 23
TRAZODONE HCL 79 79 22 63
ENALAPRIL MALEATE 76 76 24 27
TRAMADOL HCL 74 74 25 28
ESCITALOPRAM OXALATE 71 71 26 51
DIOVAN 71 71 26 17
PANTOPRAZOLE SODIUM 71 71 26 42
MELOXICAM 65 65 29 49
TAMSULOSIN HCL 65 65 29 29
METFORMIN HCL 65 65 29 7
ZOLPIDEM TARTRATE 64 64 32 14
ATENOLOL 64 64 32 18
CIPROFLOXACIN HCL 64 64 32 84
CARVEDILOL 61 61 35 19
CLOPIDOGREL 61 61 35 33
CRESTOR 60 60 37 16
ALENDRONATE SODIUM 59 59 38 25
BUSPIRONE HCL 56 56 39 153
ALLOPURINOL 55 55 40 50
CITALOPRAM HBR 54 54 41 45
QUETIAPINE FUMARATE 52 52 42 75
RAMIPRIL 51 51 43 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.